| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Michael Rapp last filed a Form 4 in October 2023, as Director at IMNM. Michael Rapp's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
Historically, Michael Rapp's trades have earned a below-average insider score of 20/100 across 6 rated trades. Over a 12-month horizon, none of those trades were profitable, with an average 12-month return of -77.8%.
At the last filing, the largest reported position was 1,071,172 shares of IMNM. Net of sales, the IMNM filings show accumulation of 208,742 shares.
Michael Rapp has 10 Form 4 filings on record from October 2020 to October 2023, all as Director at Immunome (IMNM), 2020–2023.
The 15 reported transactions were 8 open-market purchases, 4 option or other derivative awards, 2 stock awards and 1 conversion.
Counted by filing, the open-market trades come to 4 purchases worth about $3.3M and no sales.
The largest open-market purchase was 83,332 shares of IMNM at an average $12.00 on October 6, 2020, about $1.0M.
Shares as reported in the last Form 4 for each company; the most recent is from October 2023. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 13, 2021 | IMNM Immunome Inc. | Director | Buy | 25,962 | $19.96 | $518,201.52 | +14.2% | -19.6% | -76.0% | |
| Sep 10, 2021 | IMNM Immunome Inc. | Director | Buy | 45,950 | $18.07 | $830,448.60 | +33.6% | -9.1% | -71.3% | |
| May 26, 2021 | IMNM Immunome Inc. | Director | Buy | 53,498 | $18.38 | $983,423.06 | +64.2% | -29.8% | -83.4% | |
| Oct 6, 2020 | IMNM Immunome Inc. | Director | Buy | 83,332 | $12.00 | $999,984.00 | +15.0% | - | - |